185 related articles for article (PubMed ID: 35216446)
1. Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.
Chupradit K; Khamaikawin W; Sakkhachornphop S; Puaninta C; Torbett BE; Borwornpinyo S; Hongeng S; Wattanapanitch M; Tayapiwatana C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216446
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
Anderson J; Akkina R
Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172
[TBL] [Abstract][Full Text] [Related]
3. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy.
Anderson JS; Bandi S; Kaufman DS; Akkina R
Retrovirology; 2006 Apr; 3():24. PubMed ID: 16623949
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.
Banerjea A; Li MJ; Bauer G; Remling L; Lee NS; Rossi J; Akkina R
Mol Ther; 2003 Jul; 8(1):62-71. PubMed ID: 12842429
[TBL] [Abstract][Full Text] [Related]
6. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
[TBL] [Abstract][Full Text] [Related]
7. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Bai J; Banda N; Lee NS; Rossi J; Akkina R
Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
[TBL] [Abstract][Full Text] [Related]
8. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
[TBL] [Abstract][Full Text] [Related]
9. Modulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process.
Moonmuang S; Saoin S; Chupradit K; Sakkhachornphop S; Israsena N; Rungsiwiwut R; Tayapiwatana C
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30068696
[TBL] [Abstract][Full Text] [Related]
10. The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration.
Porcellini S; Alberici L; Gubinelli F; Lupo R; Olgiati C; Rizzardi GP; Bovolenta C
Blood; 2009 Apr; 113(15):3443-52. PubMed ID: 19211937
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration.
Sakkhachornphop S; Barbas CF; Keawvichit R; Wongworapat K; Tayapiwatana C
Hum Gene Ther; 2012 Sep; 23(9):932-42. PubMed ID: 22429108
[TBL] [Abstract][Full Text] [Related]
12. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
[TBL] [Abstract][Full Text] [Related]
13. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny.
Dimitrova DI; Yang X; Reichenbach NL; Karakasidis S; Sutton RE; Henderson EE; Rogers TJ; Suhadolnik RJ
J Interferon Cytokine Res; 2005 Jun; 25(6):345-60. PubMed ID: 15957958
[TBL] [Abstract][Full Text] [Related]
15. TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages.
Anderson J; Akkina R
Mol Ther; 2005 Oct; 12(4):687-96. PubMed ID: 16081321
[TBL] [Abstract][Full Text] [Related]
16. Intracellular immunization of rhesus CD34+ hematopoietic progenitor cells with a hairpin ribozyme protects T cells and macrophages from simian immunodeficiency virus infection.
Rosenzweig M; Marks DF; Hempel D; Heusch M; Kraus G; Wong-Staal F; Johnson RP
Blood; 1997 Dec; 90(12):4822-31. PubMed ID: 9389699
[TBL] [Abstract][Full Text] [Related]
17. Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection.
Rosenzweig M; Marks DF; Hempel D; Lisziewicz J; Johnson RP
J Virol; 1997 Apr; 71(4):2740-6. PubMed ID: 9060627
[TBL] [Abstract][Full Text] [Related]
18. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.
Bahner I; Kearns K; Hao QL; Smogorzewska EM; Kohn DB
J Virol; 1996 Jul; 70(7):4352-60. PubMed ID: 8676458
[TBL] [Abstract][Full Text] [Related]
19. CD25 preselective anti-HIV vectors for improved HIV gene therapy.
Kalomoiris S; Lawson J; Chen RX; Bauer G; Nolta JA; Anderson JS
Hum Gene Ther Methods; 2012 Dec; 23(6):366-75. PubMed ID: 23216020
[TBL] [Abstract][Full Text] [Related]
20. Rescue of multi-lineage hematopoiesis during HIV-1 infection by human c-mpl gene transfer and reconstitution of CD34+ progenitor cells in vivo.
Zhang M; Poh TY; Louache F; Sundell IB; Yuan J; Evans S; Koka PS
J Stem Cells; 2009; 4(3):161-77. PubMed ID: 20232601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
